Search Results

Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has signed an agreement with Janssen Research & Development, LLC (Janssen).

Elektrofi, Inc. announced that it has entered a multi-target worldwide research collaboration and license agreement with Janssen Biotech, Inc., a Johnson & Johnson company.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that 20 company-sponsored presentations from its nipocalimab and autoantibody diseases research program will be showcased at the 2023 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Meeting from November 1-4 in Phoenix, Arizona.

Predicine, Inc., a leading molecular insights company, announced a collaboration with Janssen Pharmaceutica NV, a Johnson & Johnson company.

Inhibikase Therapeutics, Inc. today announced expansion of its therapeutic pipeline and multiple updates to its Research and Development programs.

Macomics Ltd, a leader in macrophage drug discovery, announces that it has entered a scientific collaboration with Prof. Andrea Alimonti at IOR, one of Switzerland’s leading research institutes.

Providence Therapeutic Holdings Inc. and the Ontario Institute for Cancer Research, Ontario’s largest publicly funded cancer research institute delivering real-world solutions to people affected by cancer, announced the signing of a collaboration agreement for mRNA drug discovery and development.

Celularity Inc. announced today it will host an on-site and virtual Investor and Analyst Research & Development Day.

SpyBiotech, a biotechnology company with novel vaccine platform technologies that can target infectious diseases, cancer, and chronic diseases, announced a sponsored research agreement with The University of Oxford for the development of a vaccine against Epstein-Barr virus.